Axogen SEC filings
Filter: All · 8-K · 10-Q · 10-K · Form 4
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedAxogen Q3 2026 Adjusted EPS of $0.21 Beats $0.13 Consensus on $75.8 Million Revenue; Full-Year Revenue Guidance Raised to At Least $290 Million
Regulation FD disclosure · Financial statements and exhibits
Entry into a material definitive agreement · Regulation FD disclosure · Financial statements and exhibits
Entry into a material definitive agreement · Regulation FD disclosure · Other events · Financial statements and exhibits
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits